CN Creative announced today that it has been acquired by British American Tobacco as part of the FTSE 100 Company’s long term commitment to tobacco harm reduction.
CN Creative, which has its own research and development facilities, currently has several e-cigarette products on the market as well as new, innovative e-cigarette technologies in the development pipeline.
Kingsley Wheaton, Director of Corporate and Regulatory Affairs at British American Tobacco, said:
“Our core business is, and will remain in, tobacco but we’ve always made it clear that our goal is to provide those adult smokers who are seeking safer alternatives to cigarettes with a range of reduced-risk products that will meet their varying needs. We believe the innovative e-cigarette technologies that CN Creative has been developing over the past few years will help us move closer to achieving this goal.”
The acquisition of CN Creative is a natural extension of British American Tobacco’s approach to tobacco harm reduction that has been evolving over a number of years.
CN Creative’s founders Chris Lord and David Newns explained: “This is an exciting opportunity that allows us to accelerate the development and successful launch of our innovative and new e-cigarette technologies”
British American Tobacco Press Office
Will Hill/ Jem Maidment
+44 (0) 20 7845 2888 (24 hours)
British American Tobacco Investor Relations
Rachael Brierley +44 (0) 20 7845 1519
CN Creative Press Office
Nick Henderson/Richard McCann +44 (0) 845 500 1140
For website see www.cncbio.com